IA
AQST icon

IFP Advisors’s Aquestive Therapeutics AQST Stock Holding History

IFP Advisors’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Hold
3,001
– – ﹤0.01% 3255
2026
Q1 		$12.5K Buy
3,001
+1,500
+100% +$6.09K ﹤0.01% 3050
2025
Q4 		$9.7K Buy
1,501
+1,500
+150,000% +$9.35K ﹤0.01% 3081
2025
Q3 		$6 Buy
+1
New +$4 ﹤0.01% 4796
2025
Q2 		– Hold
0
– – – 3894
2025
Q1 		– Sell
-10
Closed -$36 – 4320
2024
Q4 		$36 Buy
+10
New +$46 ﹤0.01% 4336
2023
Q1 		– Sell
-6,500
Closed -$104K – 3399
2022
Q4 		$104K Hold
6,500
– – ﹤0.01% 1719
2022
Q3 		$104K Sell
6,500
-500
-7% -$565 ﹤0.01% 1830
2022
Q2 		$112K Hold
7,000
– – ﹤0.01% 1609
2022
Q1 		$112K Buy
+7,000
New +$20.4K ﹤0.01% 1609

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

IFP Advisors's AQST Position: Q2 2026 in Review

IFP Advisors held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 3,001 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

IFP Advisors first reported a position in AQST in Q1 2022 and has held it in 9 quarters since. The position peaked at $112K in Q2 2022. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • IFP Advisors held 3,001 shares of Aquestive Therapeutics worth $12.5K as of Q2 2026.
  • IFP Advisors left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3255 holding.
  • IFP Advisors first reported a position in Aquestive Therapeutics in Q1 2022 and has held it in 9 quarters since.
  • IFP Advisors's Aquestive Therapeutics position peaked at $112K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.